Novel integrated approaches for brucellosis prevention control and eradication using brucellin derived tools in production animals
Novel integrated approaches for brucellosis prevention, control and eradication using brucellin-derived tools in production animals
Project summary
Brucellae are highly contagious zoonotic bacteria, causing great losses in animal husbandry and wildlife preservation. The core Brucella species are characterised by surface smooth lipopolysaccharide (S-LPS) and lack of specific pathogen-associated molecular patterns. The majority of serological tests use Brucella LPS as an antigen, although it cross-reacts with antibodies against other bacteria, triggering strong humoral false-positive serological reactions (FPSR) which lowers test specificity. To avoid economically devastating culling of FPSR animals, the confirmatory Brucellin skin test (BST), based on the innate allergic type three or type four reaction is used. This test uses LPS-free mixture of inner highly Brucella spp. specific bacterial proteins, which does not cause formation of specific antibodies. However, stand-ardizing Brucellin is a complex due to its components’ variability, and batch controls in sensitized guinea pigs. Moreover, repeated inoculations can elicit antibodies production and anergy of immune system.
Several specific Brucella intracellular proteins have been shown to stimulate individually humoral immune responses in the same manner, making them promising replacements. In addition, concentrations of interferon gamma and other pro-inflammatory cytokines are high during Brucella infection in many species, stimulating Th1 and Th2 immune responses. Our project aims to investigate the efficacy of various Brucellin batches and standardize in vitro batch potency testing, removing reliance on exper-imental animals. Furthermore, using advanced shotgun proteomics and single-cell analyses on Brucellin antigens and host blood samples, interactions will be modelled to identify innate immune infection markers, such as IFN-gamma. These markers will be used for new ex vivo stimulation assays of peripheral blood mononuclear cells to confirm Brucella infected animals and reduce FPSR.
Priority Area 2
Procedures, methodologies and tools to analyse animal health and welfareACRONYM: BRUCELLIN
CALL: 1
DURATION: 36 months
STARTING DATE: December 2025
Key words
Partners
French Agency for Food, Environmental & Occupational Health & Safety (ANSES) - Friedrich Loeffler Institut - INIAV - CEA - Arsia laboratory - Italian National Council of researchers (CNR) - Sciensano - Istituto Zooprofilattico Sperimentale Teramo
